Gel - ANVISA Registration 81505600003

Access comprehensive regulatory information for Gel in Brazil's medical device market through Pure Global AI's free database. This Risk Class I medical device is registered under ANVISA number 81505600003 and manufactured by BIOPLAX LIMITED. The registration is held by MR PHARMA LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including RMC - INDÚSTRIA BRASILEIRA DE PRODUTOS MÉDICOS LTDA, HELIANTO FARMACEUTICA LTDA, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
81505600003
Registration Details
ANVISA Registration Number: 81505600003
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

Aftamed Junior Gel 1mL e 15mL
Risk Class I

Registration Details

81505600003

25351612941201879

23668196000192

Company Information

BIOPLAX LIMITED
United Kingdom
PT: REINO UNIDO

Dates and Status

Oct 01, 2018

VIGENTE

09/18/2025 19:00:01